- Home
- DNA vs EOI Comparison
DNA vs EOI Comparison
Compare DNA & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- EOI
- Stock Information
- Founded
- DNA 2008
- EOI 2004
- Country
- DNA United States
- EOI United States
- Employees
- DNA 834
- EOI N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- EOI Finance/Investors Services
- Sector
- DNA Health Care
- EOI Finance
- Exchange
- DNA Nasdaq
- EOI Nasdaq
- Market Cap
- DNA 731.1M
- EOI 870.1M
- IPO Year
- DNA N/A
- EOI N/A
- Fundamental
- Price
- DNA $12.42
- EOI $21.38
- Analyst Decision
- DNA Hold
- EOI
- Analyst Count
- DNA 2
- EOI 0
- Target Price
- DNA $9.50
- EOI N/A
- AVG Volume (30 Days)
- DNA 1.6M
- EOI 83.6K
- Earning Date
- DNA 08-07-2025
- EOI 01-01-0001
- Dividend Yield
- DNA N/A
- EOI 7.19%
- EPS Growth
- DNA N/A
- EOI N/A
- EPS
- DNA N/A
- EOI N/A
- Revenue
- DNA $230,815,000.00
- EOI N/A
- Revenue This Year
- DNA N/A
- EOI N/A
- Revenue Next Year
- DNA $13.73
- EOI N/A
- P/E Ratio
- DNA N/A
- EOI N/A
- Revenue Growth
- DNA 25.21
- EOI N/A
- 52 Week Low
- DNA $5.00
- EOI $14.36
- 52 Week High
- DNA $16.85
- EOI $18.88
- Technical
- Relative Strength Index (RSI)
- DNA 49.28
- EOI 61.38
- Support Level
- DNA $11.92
- EOI $21.17
- Resistance Level
- DNA $12.81
- EOI $21.32
- Average True Range (ATR)
- DNA 0.99
- EOI 0.19
- MACD
- DNA -0.13
- EOI 0.01
- Stochastic Oscillator
- DNA 38.37
- EOI 93.52
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation.